Biotech Investors & VC Firms in India
108 firms in this list, with a median first check of $500K. 27 of them lead rounds. Generated from verified public data and updated continuously.
Abbhi Capital
MiamiPre-Seed–Late Stage
JAFCO Group
TokyoPre-Seed–Late Stage$1.9M – $198M
Capstone Partners Korea
SeoulSeed–Series B$223K – $12M
Mitsui Sumitomo Insurance Capital
TokyoPre-Seed–Late Stage$1.1M – $198M
1 person
Biomark Capital
GreenwichSeries A–Late Stage$5M – $10M
4 people
Fosun Pharma
Shanghai
D3 Jubilee
SeoulSeed–Late Stage
Ela Capital
TorontoPre-Seed–Growth
IBK Capital
SeoulSeed–Series B$2K – $21M
Japan Asia Investment
TokyoPre-Seed–Late Stage$1M – $10M
1 person
ePlanet Capital
San JoseSeed–Late Stage
3 people
HSBC Innovation Ventures
LondonSeed–Growth
1 person
Related lists
Investors & VC Firms in North America (14143)Investors & VC Firms in United States (13281)Investors & VC Firms in Europe (5575)Crypto & Web3 Investors & VC Firms (4830)Investors & VC Firms in Global (4158)SaaS Investors & VC Firms (3865)AI & Machine Learning Investors & VC Firms (3769)Fintech Investors & VC Firms (3726)Investors & VC Firms in Asia-Pacific (3574)Healthtech Investors & VC Firms (3415)
Data sourced from public filings and firms' own websites — see our methodology.




